Researchers are excited about the medication , a novel dual compound showing significant outcomes in clinical trials for body loss . It acts by targeting several pathways : GLP-1 and GIP, these, when https://anyabozs742552.blogsuperapp.com/41302962/the-new-possibility-for-body-management